CH Biotech R&D Co., Ltd. (6534.TW)

TWD 80.6

(-0.49%)

Revenue Summary of CH Biotech R&D Co., Ltd.

  • CH Biotech R&D Co., Ltd.'s latest annual revenue in 2023 was 1.51 Billion TWD , up 5.63% from previous year.
  • CH Biotech R&D Co., Ltd.'s latest quarterly revenue in 2024 Q2 was 400.72 Million TWD , down -51.42% from previous quarter.
  • CH Biotech R&D Co., Ltd. reported a annual revenue of 1.43 Billion TWD in annual revenue 2022, up 40.81% from previous year.
  • CH Biotech R&D Co., Ltd. reported a annual revenue of 1.01 Billion TWD in annual revenue 2021, up 45.05% from previous year.
  • CH Biotech R&D Co., Ltd. reported a quarterly revenue of 824.8 Million TWD for 2024 Q1, up 473.85% from previous quarter.
  • CH Biotech R&D Co., Ltd. reported a quarterly revenue of 143.73 Million TWD for 2023 Q4, up 29.56% from previous quarter.

Annual Revenue Chart of CH Biotech R&D Co., Ltd. (2023 - 2019)

Historical Annual Revenue of CH Biotech R&D Co., Ltd. (2023 - 2019)

Year Revenue Revenue Growth
2023 1.51 Billion TWD 5.63%
2022 1.43 Billion TWD 40.81%
2021 1.01 Billion TWD 45.05%
2020 702.18 Million TWD -16.47%
2019 840.68 Million TWD 0.0%

Peer Revenue Comparison of CH Biotech R&D Co., Ltd.

Name Revenue Revenue Difference
Sinon Corporation 19.11 Billion TWD 92.074%
Taiwan Fertilizer Co., Ltd. 15.01 Billion TWD 89.911%
All Cosmos Bio-Tech Holding Corporation 2.82 Billion TWD 46.408%